Azenta, Inc. - Common Stock (NQ:AZTA)

42.73 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Azenta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

What To Know About Evercore ISI Group's Downgrade of Azenta ↗

January 03, 2023

Via Benzinga

Sea, UiPath, J&J Snack Foods And Other Big Gainers From Tuesday ↗

November 16, 2022

U.S. stocks closed higher on Tuesday, with the Nasdaq Composite gaining more than 150 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 15, 2022

Via Benzinga

Azenta Surges To Two-Month High On $1.5 Billion Buyback Despite Covid Decline ↗

November 15, 2022

The company says excluding the impact of Covid contributions, sales rose 12%.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 15, 2022

Gainers Azenta (NASDAQ:AZTA) shares rose 32.5% to $61.74 during Tuesday's pre-market session. The company's market cap stands at $4.6 billion. As per the news, the Q4 earnings report came out...

Via Benzinga

Azenta's Enhances Position in Cold Chain Solutions With €410M Acquisition ↗

August 09, 2022

Via Benzinga

Azenta Shares Plunge After Q3 Preliminary Results ↗

July 13, 2022

Via Benzinga

Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday ↗

November 16, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.

Via Benzinga

Azenta Shares Tick Higher After Q4 Earnings Surpass Estimates, $1.5B Share Buyback ↗

November 15, 2022

Via Benzinga

Expert Ratings for Azenta ↗

May 17, 2022

Within the last quarter, Azenta (NASDAQ:AZTA) has observed the following analyst ratings:

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗

November 15, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 15, 2022

We're starting off the day with a look at the biggest pre-market stock movers that traders will want to know about for Tuesday morning!

Via InvestorPlace

HUYA, Tencent Music Entertainment, Taiwan Semiconductor Manufacturing, And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 15, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 18, 2022

During Thursday's trading, 62 companies set new 52-week lows.

Via Benzinga

The 3 Best Tech ETFs to Buy Now ↗

August 14, 2022

The best tech ETFs enable investors to, with relatively low risk, exploit the most momentous, technical changes in society.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

August 10, 2022

During Wednesday, 52 stocks hit new 52-week lows.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 20, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday ↗

July 15, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 14, 2022

Via Benzinga

Why Is Conagra Brands Dropping By More Than 8%? 43 Stocks Moving In Thursday's Mid-Day Session ↗

July 14, 2022

Gainers Shineco, Inc. (NASDAQ: SISI) shares climbed 24.5% to $1.2201 on heavy volume.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 14, 2022

Via Benzinga

U.S. Stock Futures Down Ahead Of Bank Earnings, Producer Price Index ↗

July 14, 2022

Pre-open movers

Via Benzinga

JPMorgan, Morgan Stanley And 3 Stocks To Watch Heading Into Thursday ↗

July 14, 2022

With the US stock futures trading lower this morning on Tuesday ahead of earnings from big banks, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 13, 2022

Gainers

Via Benzinga

$100 Invested In Azenta 15 Years Ago Would Be Worth This Much ↗

March 21, 2022

Azenta (NASDAQ:AZTA) has outperformed the market over the past 15 years by 3.62% on an annualized basis. Buying $100 In AZTA: 15 years ago, an investor could have purchased 5.88...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2022 ↗

March 21, 2022

Upgrades According to B. Riley Securities, the prior rating for BRT Apartments Corp (NYSE:BRT) was changed from Neutral to Buy. BRT Apartments earned $0.41 in the fourth quarter,...

Via Benzinga

Azenta: Q1 Earnings Insights ↗

February 08, 2022

Azenta (NASDAQ:AZTA) reported its Q1 earnings results on Tuesday, February 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Azenta beat estimated earnings by...

Via Benzinga

2022 Tech Trends That Will Change Our World And The Potential Beneficiaries: Deloitte Report ↗

December 30, 2021

The year 2021 marked a period when global economies began picking up the pieces following the COVID-19 pandemic that left them crippled and ravaged. Notwithstanding the setbacks,...

Via Benzinga

Earnings Scheduled For February 8, 2022 ↗

February 08, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.